MX2007012567A - Combinacion para terapia en hiperplasia benigna de prostata. - Google Patents
Combinacion para terapia en hiperplasia benigna de prostata.Info
- Publication number
- MX2007012567A MX2007012567A MX2007012567A MX2007012567A MX2007012567A MX 2007012567 A MX2007012567 A MX 2007012567A MX 2007012567 A MX2007012567 A MX 2007012567A MX 2007012567 A MX2007012567 A MX 2007012567A MX 2007012567 A MX2007012567 A MX 2007012567A
- Authority
- MX
- Mexico
- Prior art keywords
- benign prostate
- prostate hyperplasia
- case
- therapeutic combination
- inhibitor
- Prior art date
Links
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title 1
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 abstract 2
- 229940123333 Phosphodiesterase 5 inhibitor Drugs 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000002590 phosphodiesterase V inhibitor Substances 0.000 abstract 2
- 229940123934 Reductase inhibitor Drugs 0.000 abstract 1
- 239000000674 adrenergic antagonist Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005016981A DE102005016981A1 (de) | 2005-04-13 | 2005-04-13 | Kombination zur Therapie bei benigner Prostatahyperplasie |
| PCT/EP2006/002941 WO2006108519A1 (fr) | 2005-04-13 | 2006-03-31 | Combinaison pour traiter une hyperplasie benigne de la prostate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007012567A true MX2007012567A (es) | 2007-12-10 |
Family
ID=36608700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007012567A MX2007012567A (es) | 2005-04-13 | 2006-03-31 | Combinacion para terapia en hiperplasia benigna de prostata. |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1888075A1 (fr) |
| JP (1) | JP2008535877A (fr) |
| KR (1) | KR20080007252A (fr) |
| CN (1) | CN101193638A (fr) |
| AR (1) | AR053575A1 (fr) |
| AU (1) | AU2006233567A1 (fr) |
| BR (1) | BRPI0610634A2 (fr) |
| CA (1) | CA2605224A1 (fr) |
| CR (1) | CR9427A (fr) |
| DE (1) | DE102005016981A1 (fr) |
| DO (1) | DOP2006000074A (fr) |
| GT (1) | GT200600145A (fr) |
| IL (1) | IL186604A0 (fr) |
| MA (1) | MA29683B1 (fr) |
| MX (1) | MX2007012567A (fr) |
| PE (1) | PE20061338A1 (fr) |
| RU (1) | RU2007141518A (fr) |
| SV (1) | SV2008002477A (fr) |
| TN (1) | TNSN07385A1 (fr) |
| TW (1) | TW200716122A (fr) |
| UY (1) | UY29473A1 (fr) |
| WO (1) | WO2006108519A1 (fr) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6143746A (en) * | 1994-01-21 | 2000-11-07 | Icos Corporation | Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use |
| WO2007047282A1 (fr) * | 2005-10-12 | 2007-04-26 | Lilly Icos Llc | Traitement d'une hypertrophie benigne de la prostate et de symptomes dans les voies urinaires inferieures |
| WO2007072156A1 (fr) * | 2005-12-21 | 2007-06-28 | Pfizer Products Inc. | Combinaison pharmaceutique d'un inhibiteur de pde-5 et d'un inhibiteur de 5-alpha reductase |
| WO2008005039A1 (fr) * | 2006-07-07 | 2008-01-10 | Teva Pharmaceutical Industries Ltd. | Compositions solides comprenant du tadalafil et au moins un véhicule |
| DE102007028869A1 (de) | 2007-06-22 | 2008-12-24 | Ratiopharm Gmbh | Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil |
| MX2010006520A (es) * | 2007-12-13 | 2010-11-30 | Vanda Pharmaceuticals Inc | Metodo y composicion para el tratamiento de una condicion mediada por alfa-adrenoceptor. |
| DK2222300T3 (da) | 2007-12-13 | 2014-07-21 | Vanda Pharmaceuticals Inc | Fremgangsmåde og præparat til behandling af en serotoninreceptormedieret tilstand |
| US8737368B2 (en) | 2010-04-26 | 2014-05-27 | Intel Corporation | Method, apparatus and system for switching traffic streams among multiple frequency bands |
| WO2013123965A1 (fr) * | 2012-02-20 | 2013-08-29 | Synthon Bv | Formulation pharmaceutique à dose fixe |
| CN102727456B (zh) * | 2012-07-03 | 2016-06-22 | 北京科信必成医药科技发展有限公司 | 药物口腔崩解片及其制备方法 |
| CN105338970B (zh) * | 2013-06-28 | 2019-07-09 | 韩美药品株式会社 | 包含他达拉非和坦洛新的药物胶囊复合制剂 |
| DK3024474T3 (da) | 2013-07-23 | 2022-03-28 | Serenity Pharmaceuticals Llc | Sammensætninger omfattende desmopressin i kombination med en beta-3-adrenoreceptor-agonist |
| KR101663238B1 (ko) * | 2013-11-15 | 2016-10-14 | 한미약품 주식회사 | 타다라필 및 암로디핀을 포함하는 복합 고형 제제 |
| MY181172A (en) * | 2014-06-30 | 2020-12-21 | Hanmi Pharm Ind Co Ltd | Composite preparation comprising active ingredient-containing film coating layer |
| WO2016003181A1 (fr) * | 2014-06-30 | 2016-01-07 | 한미약품 주식회사 | Préparation composite comprenant une couche de revêtement par film contenant un principe actif |
| KR20160002411A (ko) * | 2014-06-30 | 2016-01-07 | 한미약품 주식회사 | 5-α-환원효소 억제제-함유 필름 코팅층을 포함하는 복합제제 및 그 제조방법 |
| EP3220942B1 (fr) * | 2014-11-20 | 2022-04-27 | Serenity Pharmaceuticals LLC | Compositions comprenant de la desmopressine a faible dose combinée à un antagoniste du récepteur alpha-adrénergique |
| KR102391495B1 (ko) * | 2016-03-31 | 2022-04-28 | 한미약품 주식회사 | 안정성 및 용출율이 개선된 타다라필 및 탐수로신 함유 캡슐 복합제제 |
| KR101835506B1 (ko) * | 2016-10-25 | 2018-03-07 | 주식회사 에스텍파마 | 두타스테리드와 타다라필을 함유하는 속효성 복합정제 |
| CN108066347B (zh) * | 2016-11-16 | 2021-02-02 | 深圳万和制药有限公司 | 包含坦索罗辛和度他雄胺的口腔崩解片药物组合物 |
| KR101879133B1 (ko) * | 2017-07-11 | 2018-07-17 | (주)동구바이오제약 | 비뇨기 질환 예방 또는 치료용 제제 및 이의 제조방법 |
| TR201715231A2 (tr) * | 2017-10-09 | 2019-04-22 | Montero Gida Sanayi Ve Ticaret Anonim Sirketi | Dapokseti̇n ve fosfodi̇esteraz ti̇p-5 i̇nhi̇bi̇törü i̇çeren farmasöti̇k kombi̇nasyon |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050042177A1 (en) * | 2003-07-23 | 2005-02-24 | Elan Pharma International Ltd. | Novel compositions of sildenafil free base |
-
2005
- 2005-04-13 DE DE102005016981A patent/DE102005016981A1/de not_active Withdrawn
-
2006
- 2006-03-29 DO DO2006000074A patent/DOP2006000074A/es unknown
- 2006-03-31 MX MX2007012567A patent/MX2007012567A/es not_active Application Discontinuation
- 2006-03-31 CN CNA2006800207814A patent/CN101193638A/zh active Pending
- 2006-03-31 EP EP06723901A patent/EP1888075A1/fr not_active Withdrawn
- 2006-03-31 WO PCT/EP2006/002941 patent/WO2006108519A1/fr not_active Ceased
- 2006-03-31 RU RU2007141518/15A patent/RU2007141518A/ru unknown
- 2006-03-31 KR KR1020077026260A patent/KR20080007252A/ko not_active Withdrawn
- 2006-03-31 CA CA002605224A patent/CA2605224A1/fr not_active Abandoned
- 2006-03-31 BR BRPI0610634-0A patent/BRPI0610634A2/pt not_active Application Discontinuation
- 2006-03-31 JP JP2008505765A patent/JP2008535877A/ja active Pending
- 2006-03-31 AU AU2006233567A patent/AU2006233567A1/en not_active Abandoned
- 2006-04-07 SV SV2006002477A patent/SV2008002477A/es not_active Application Discontinuation
- 2006-04-10 GT GT200600145A patent/GT200600145A/es unknown
- 2006-04-11 PE PE2006000383A patent/PE20061338A1/es not_active Application Discontinuation
- 2006-04-11 AR ARP060101410A patent/AR053575A1/es unknown
- 2006-04-12 UY UY29473A patent/UY29473A1/es not_active Application Discontinuation
- 2006-04-12 TW TW095112920A patent/TW200716122A/zh unknown
-
2007
- 2007-10-09 CR CR9427A patent/CR9427A/es not_active Application Discontinuation
- 2007-10-11 IL IL186604A patent/IL186604A0/en unknown
- 2007-10-11 TN TNP2007000385A patent/TNSN07385A1/en unknown
- 2007-10-29 MA MA30335A patent/MA29683B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR053575A1 (es) | 2007-05-09 |
| BRPI0610634A2 (pt) | 2010-07-13 |
| GT200600145A (es) | 2007-04-10 |
| SV2008002477A (es) | 2008-02-08 |
| MA29683B1 (fr) | 2008-08-01 |
| DOP2006000074A (es) | 2006-10-15 |
| UY29473A1 (es) | 2006-11-30 |
| CN101193638A (zh) | 2008-06-04 |
| JP2008535877A (ja) | 2008-09-04 |
| WO2006108519A1 (fr) | 2006-10-19 |
| AU2006233567A1 (en) | 2006-10-19 |
| PE20061338A1 (es) | 2007-01-28 |
| IL186604A0 (en) | 2008-01-20 |
| CR9427A (es) | 2007-12-17 |
| EP1888075A1 (fr) | 2008-02-20 |
| TW200716122A (en) | 2007-05-01 |
| DE102005016981A1 (de) | 2006-10-19 |
| CA2605224A1 (fr) | 2006-10-19 |
| KR20080007252A (ko) | 2008-01-17 |
| TNSN07385A1 (en) | 2009-03-17 |
| RU2007141518A (ru) | 2009-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN07385A1 (en) | Therapeutic combination in case of benign prostate hyperplasia | |
| SG164368A1 (en) | Treatment of cancer | |
| IL260127B (en) | mek inhibitors and methods of using them | |
| MX2009005011A (es) | Imidazopirazinas como inhibidores de proteina quinasa. | |
| WO2007051065A3 (fr) | Compositions et traitements destines a inhiber kinase et/ou hmg-coa reductase | |
| TW200801008A (en) | Protein kinase inhibitors | |
| NO20052888L (no) | Diamintriazoler anvendelige som inhibitorer av proteinkinaser | |
| TW200607525A (en) | Compositions for delivering highly water soluble drugs | |
| MX2010006154A (es) | Tratamiento del cancer con combinaciones de inhibidores de la topoisomerasa e inhibidores de la poli-adp-ribosa-polimerasa. | |
| WO2008076278A8 (fr) | Procédés de traitements | |
| UY29246A1 (es) | Nuevos compuestos | |
| MX2009013729A (es) | Imidazopirazinas como inhibidores de proteina quinasa. | |
| NO20070866L (no) | Antivirale forbindelser. | |
| TW200604168A (en) | Azaindoles useful as inhibitors of rock and other protein kinases | |
| WO2008030883A3 (fr) | Traitement du cancer | |
| TNSN07193A1 (en) | Pharmaceutical compositions comprising a camptothecin derivate | |
| MX2009002842A (es) | Inhibidores heterociclicos de c-met y usos de los mismos. | |
| TW200630090A (en) | Triazoles useful as inhibitors of protein kinases | |
| MX2007004264A (es) | Uso de inhibidores de cinasas jun n-terminales para el tratamiento de retinopat??a glaucomatosa y enfermedades oculares. | |
| WO2006113483A3 (fr) | Methodes et compositions pour le traitement ou la prevention du cancer | |
| MXPA04011835A (es) | Tratamiento de combinacion para la depresion y ansiedad. | |
| TR200102448T2 (tr) | COPD tedavisi için kontrollu salma formülasyonu. | |
| MXPA05011213A (es) | Combinacion de un inhibidor de ciclooxigenasa-2 y un agente antineoplasico tipo alquilacion para tratamiento de neoplasia. | |
| WO2006028524A3 (fr) | Compositions et traitements pour l'inhibition de kinase et/ou de hmg-coa reductase | |
| WO2005053725A3 (fr) | Traitement anticancereux |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |